Meet the editor

Julia O. Fedotova, MD, Ph.D. habil., Sc.D. graduated with a degree in Pharmacy from the Pharmaceutical Faculty, St. Petersburg State Chemical Pharmaceutical Academy, Russia, in 1996. She completed post-graduate training and obtained a Ph.D. in Experimental and Clinical Pharmacology and in Physiology of Humans and Animals in 1999. She completed additional training in the Department of Pharmacology, Med-

ical School, University of Catania, Italy, in 2002, and the Institute of Physiology, Medical School, University of Pecs, Hungary in 2003-2004. She graduated with a doctorate in Neuropharmacology from the Department of Neuropharmacology, Institute for Experimental Medicine, Russian Academy of Medical Sciences, and received a Dr. habil in Biological Sciences in 2008. Dr. Fedotova is a leading researcher and principal investigator at the I.P. Pavlov Institute of Physiology, Russian Academy of Sciences and ITMO University, Russia. She has 2 grants and more than 250 publications to her credit, including 5 books and 6 book chapters. She has also edited one book. Dr. Fedotova studied the role of vitamin D in the development of affective-related disorders in women with a grant from the Russian Scientific Foundation.

## Contents


*by Fatemeh Gholami, Saman Farshid, Parmida Soleimani and Rohollah Valizadeh*


Preface

Vitamin D deficiency has been noted in people worldwide and thus it is a global problem. As such, there is growing interest from scholars and health practitioners in the function of vitamin D in human health and diseases, especially in its pleiotropic outcomes. It is generally accepted that vitamin D is an essential substance for the homeostasis of calcium and phosphorus in the human body. It is a neuroactive secosteroid that may be implicated in the development of various pathological disorders. The functionally active form of vitamin D (1.25-OH-VD 2) reveals both genomic and

The book presents new insights into the role of vitamin D deficiency in the development of various chronic diseases, including COVID-19. It is organized into four sections: "Introduction", "Vitamin D Status and Childhood", "Vitamin D Status and COVID-19", and "Vitamin D Status and Non-Hormonal/Hormonal Disorders".

After the first section, which is the introduction, an important theme developed in Section 2 is vitamin D status in the neonatal and postnatal periods in children. Chapters in this section examine the consequences of vitamin D deficiency in children and discuss strategies for addressing this deficiency. Section 3 discusses the profound role of vitamin D deficiency in the era of COVID-19. Finally, Section 4 reviews the implication of vitamin D deficiency in the physiological and biochemical processes

**Julia Fedotova, MD, Ph.D., Dr. habil, Sc.D.**

National Research South Ural State University,

Laboratory of Neuroendocrinology, Pavlov Institute of Physiology RAS,

Associated Professor,

St. Petersburg, Russia

Chelaybinsk, Russia

of renal, endocrine, and cardiovascular diseases.

non-genomic effects.
